Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06034652 · ClinicalTrials.gov registry record
T-GENVIH-003 LTFU (Long Term Follow Up) Study
A clinical trial, sponsored by Integra LifeSciences Corporation.
- Completed
- Registry status
- 8
- Enrollment target
NCT06034652 is a clinical trial that has completed, run by Integra LifeSciences Corporation. The registered enrollment target is 8 participants.
The verdict
NCT06034652 has completed, sponsored by Integra LifeSciences Corporation.
- COMPLETED
- Registry status
- 8 participants
- Enrollment target
Study Summary
The T-GENVIH-003 study will collect additional, longer term performance data of Gentrix® Surgical Matrix used for reinforcement of ventral hernia repairs from a subset population (i.e., the twenty-one minimally invasive surgical approach cases) from the prior T-GENVIH-002 study.
Interventions
- DEVICE Integra® Gentrix® Surgical Matrix
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2023-09-12 |
| Est. Completion | 2024-01-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06034652
The ClinicalTrials.gov registry entry for NCT06034652 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Integra® Gentrix® Surgical Matrix is the first listed.
NCT06034652 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06034652 about?
NCT06034652 is a clinical study titled "T-GENVIH-003 LTFU (Long Term Follow Up) Study". The T-GENVIH-003 study will collect additional, longer term performance data of Gentrix® Surgical Matrix used for reinforcement of ventral hernia repairs from a subset population (i.e., the twenty-one minimally invasive surgical approach cases) from the prior T-GENVIH-002 study.
What is the current status of trial NCT06034652?
This trial is currently completed. The enrollment target is 8 participants. The study started on 2023-09-12. Estimated completion is 2024-01-19.
What interventions are being tested in trial NCT06034652?
The interventions under investigation include: Integra® Gentrix® Surgical Matrix (DEVICE).
Who is sponsoring clinical trial NCT06034652?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.